The US Supreme Court has temporarily preserved the US Food and Drug Administration’s rules on access to the abortion drug mifepristone as it continues to weigh the issue.
The ruling on 14 April came after a federal appeals court upheld the FDA’s approval of mifepristone but rolled back rules that were put in place in 2016. That came after a ruling last Friday from a federal court in Texas that ruled against the FDA’s approval of mifepristone from 23 years ago, threatening access to abortion care for millions of Americans.
